Treating collagen-mediated diseases with Clostidium histolyticum collagenase I and II

摘要

Disclosed is a drug product consisting of collagenase I and collagenase II having the sequence of Clostridium histolyticum collagenase I and collagenase II respectively, having a mass ratio of about 1 to 1 with a purity of 95% by area as measured by reverse phase high performance liquid chromatography. Also disclosed are processes for producing said drug product.